Kronos Worldwide, Inc. produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics and pharmaceuticals. It also produces ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron-based chemicals, which are used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; specialty chemicals for use in the formulation of pearlescent pigments, and production of electroceramic capacitors for cell phones and other electronic devices, as well as for use in natural gas pipe, and other specialty applications. In addition, the company provides technical services for its products. It sells its products under the KRONOS brand through agents and distributors to paint, plastics, decorative laminate, and paper manufacturers. The company was founded in 1916 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.

Kronos Worldwide Inc

Oppenheimer analyst Andreas Argyrides maintained a Buy rating on Keros Therapeutics today and set a price target of $27.00. Argyrides covers the He...

Keros Therapeutics (KROS) Gets a Buy from Oppenheimer

Clear Street analyst Kaveri Pohlman maintained a Hold rating on Akero Therapeutics yesterday and set a price target of $54.00. The company’s shares...

Clear Street Keeps Their Hold Rating on Akero Therapeutics (AKRO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Staar Surgical (STAA – Research Report), Keros Therapeutics (KROS...

Current Quarter	$-0.08	Next Quarter	$NA
Current Year	$-0.06	Next Year	$0.61
QoQ Growth	NaN%	YoY Growth	+1116.7%
3Y EPS CAGR	-8.5%	Target Price	$6.75
Consensus	Buy	Upside	+48.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KRO	$4.54	+6.07%	242.66K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KRO	$4.54	+6.1%	242.66K
3
4
5
6

KRO

KRO

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Kronos Worldwide Inc Data in Excel

Get Kronos Worldwide Inc Data in Excel